Table 1 Participants and recruitment
Participants | Role | Use of EMOS |
|---|---|---|
Interviews | ||
 GP1-INT | General Practitioner | In general practice and as prescribing lead of Clinical Commissioning Group (CCG) medicines management team |
 GP2 | General Practitioner | In general practice and as respiratory lead at CCG |
 GP3 | General Practitioner | In general practice |
 CCGP1 | CCG Pharmacist | Medication reviews in care homes |
 CCGP2 | CCG Pharmacist | CCG medicines management team |
Focus group A - General Practitioners | ||
 GP4 | General Practitioner | In general practice |
 GP1-FG | General Practitioner | In practice and as prescribing lead of CCG medicines management team |
Focus group B – Community Pharmacists | ||
 CP1 | Community Pharmacist | Aware of, but no access |
 CP2 | Community Pharmacist | Aware of, but no access |
 CP3 | Community Pharmacist | Aware of, but no access |
 CP4 | Community Pharmacist | Aware of, but no access |
Focus Group C – Patients | ||
 Pt1 | Patient | Access through patient passport |
 Pt2 | Patient | Access through patient passport |
 Pt3 | Patient | Access through patient passport |
 Pt4 | Patient | Access through patient passport |
Focus Group D - General practice managers | ||
 GPM1 | General Practice Manager | In general practice |
 GPM2 | General Practice Manager | In general practice |
 GPM3 | General Practice Manager | In general practice |
 GPM4 | General Practice Manager | In general practice |
Observation | ||
 CCGP1 | CCG Pharmacist | Medication reviews in care homes |